Tafamidis Production via Copper-Catalyzed Cyclization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing tafamidis or its salts face challenges such as low yield, high cost due to expensive starting materials, and complex purification processes, which hinder industrial scalability and efficiency.
Innovation Solution
A method involving cyclization of N-[2-halo-4-(alkoxycarbonyl)phenyl]-3,5-dichlorobenzamide using one or more copper catalysts, a base, and an amine ligand to produce tafamidis or its salts in high yield and at a lower cost.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If 3-hydroxy-4-aminobenzoic acid is used as starting material for amidation, then tafamidis can be produced, but side reactions occur reducing selectivity and yield
Solution Approach 1:
The patent changes the chemical parameters by using protected amino acid derivatives (N-protected-3-amino-4-hydroxybenzoic acid) instead of the unprotected form, and employs specific coupling reagents (HATU, HBTU, EDCI) with controlled reaction conditions to minimize side reactions during amidation with 3,5-dichlorobenzoyl chloride
Solution Approach 2:
The patent introduces intermediate compounds (N-protected amide intermediates) that stabilize the reaction pathway, preventing direct unwanted reactions between 3-hydroxy-4-aminobenzoic acid and 3,5-dichlorobenzoyl chloride, thereby improving selectivity before final cyclization
2Manufacturing precision
If 3-hydroxy-4-aminobenzoic acid is used as starting material, then tafamidis can be produced, but production cost increases
Solution Approach 1:
The patent uses readily available and inexpensive starting materials (3-amino-4-hydroxybenzoic acid derivatives and 3,5-dichlorobenzoyl chloride) along with cost-effective protecting group strategies that can be easily removed, avoiding the need for expensive specialized reagents while maintaining high product quality
3Manufacturing precision
If methylation and column purification are performed, then purification is achieved, but process complexity increases
Solution Approach 1:
The patent extracts or removes the need for complex column purification by designing the synthesis pathway to produce tafamidis with sufficient purity through controlled amidation and cyclization reactions, allowing direct crystallization or simple filtration to achieve pharmaceutical grade product
Solution Approach 2:
The patent segments the synthesis into distinct protected intermediate stages where impurities can be controlled at each step, allowing simpler purification methods between steps rather than requiring complex final purification of the complete molecule
4Ease of manufacture
If large liquid volumes are used for amidation and cyclization, then reactions can proceed, but productive efficiency decreases
Solution Approach 1:
The patent optimizes reaction parameters by using concentrated reaction conditions with minimal solvent volumes, employing high-reactivity coupling reagents that allow amidation and cyclization to proceed efficiently in small volumes, thereby improving productive efficiency while maintaining reaction feasibility
5Manufacturing precision
If N-[2-hydroxy-4-carboxyphenyl]-3,5-dichlorobenzamide intermediate is used, then tafamidis can be synthesized, but filtration becomes difficult
Solution Approach 1:
The patent changes the physical parameters of the intermediate compounds through protecting group strategies and controlled reaction conditions that produce intermediates with better solubility and crystallization properties, making filtration and handling significantly easier while maintaining the ability to synthesize tafamidis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a high yield and reduces production costs by minimizing side reactions, simplifying purification, and optimizing liquid volumes, thereby facilitating industrial-scale production of tafamidis.
Implementation Method 1
cyclization of N-[2-halo-4-(alkoxycarbonyl)phenyl]-3,5-dichlorobenzamide using one or more copper catalysts
Implementation Method 2
cyclization reaction is performed using the iridium catalyst for 48 hours to obtain methyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate
Data Source
AI summary
Provided is a method allowing the production of tafamidis or a salt thereof in a high yield. The method includes a cyclization step of cyclizing a compound of the formula (1) below in the presence of one or more copper catalysts selected from the group consisting of copper halides, copper carboxylates, copper sulfates, and copper oxides, a base, and an amine ligand to obtain a compound of the formula (2) below, [in the formula (1), R1 represents a linear or branched alkyl group, and X represents a halogen atom] [in the formula (2), R1 is as defined above].